Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Pain, Postoperative 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Agnosia 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Orphenadrine × Clear all
NCT02958566 2017-03-20

Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery

University of Illinois College of Medicine at Peoria

Phase 4 Unknown
80 enrolled
GastrointestinalOther

Agnosia, Colonic Neoplasms, Constipation, Diverticulitis, Colonic, Pain, Postoperative, Rectal Neoplasms, Diverticulosis, Colonic, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡